Cours Isodiol International Inc. Canadian Securities Exchange
Actions
ISOL
CA46500L2003
Produits pharmaceutiques
CA 2018 | 19,14 M 26,08 M 17,26 M | CA 2019 | 22,25 M 30,32 M 20,06 M | Capitalisation | 49,96 M 68,07 M 45,05 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,05 M -32,47 M | Résultat net 2019 | -126 M -172 M -114 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,19 M 14,02 M | Dette nette 2019 | 5,22 M 7,12 M 4,71 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+37,29% | 6,02 Md | |
-21,28% | 4,19 Md | |
+4,52% | 3,25 Md | |
-18,16% | 2,87 Md | |
-7,70% | 2,37 Md | |
+41,50% | 1,89 Md | |
-4,05% | 1,58 Md | |
-15,56% | 1,54 Md | |
-14,62% | 1,5 Md |